During the global COVID-19 pandemic, iProcess was contracted by a major medical device/healthcare company to help prospectively collect SARS-CoV-2 samples to be used as validation materials for their novel test platform.
Challenges & Solutions
Challenge: Shortages of viral transport medium (VTM) due to high global demand. Solution: iProcess expanded supplier partnerships, securing a reliable supply chain to prevent disruptions.
Challenge: Efficient participant recruitment to meet sample volume targets. Solution: Implemented strategic outreach programs at clinics and hospitals to increase participation rates.
Outcome
Successfully supported the development of a new molecular diagnostic assay.
Provided high-quality specimens that met regulatory and clinical requirements.
Strengthened relationships with both the sponsor and sites for future collaborations.
In response to the global COVID-19 pandemic, iProcess provided crucial support of an initiative aimed at supporting the rapid deployment and expansion of SARS-CoV-2 serological…
During the global COVID-19 pandemic, iProcess was contracted by a major medical device/healthcare company to help prospectively collect SARS-CoV-2 samples to be used as validation…
